212 related articles for article (PubMed ID: 11032761)
1. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats.
Stitt AW; Bhaduri T; McMullen CB; Gardiner TA; Archer DB
Mol Cell Biol Res Commun; 2000 Jun; 3(6):380-8. PubMed ID: 11032761
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu M; Kuroki M; Amano S; Tolentino M; Keough K; Kim I; Bucala R; Adamis AP
J Clin Invest; 1998 Mar; 101(6):1219-24. PubMed ID: 9502762
[TBL] [Abstract][Full Text] [Related]
3. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
4. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
5. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
6. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
Hirata C; Nakano K; Nakamura N; Kitagawa Y; Shigeta H; Hasegawa G; Ogata M; Ikeda T; Sawa H; Nakamura K; Ienaga K; Obayashi H; Kondo M
Biochem Biophys Res Commun; 1997 Jul; 236(3):712-5. PubMed ID: 9245719
[TBL] [Abstract][Full Text] [Related]
8. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium.
Wang L; Li Q; Du J; Chen B; Li Q; Huang X; Guo X; Huang Q
Acta Diabetol; 2012 Feb; 49(1):47-55. PubMed ID: 21327982
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
12. Suppression of diabetic retinopathy with angiopoietin-1.
Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
[TBL] [Abstract][Full Text] [Related]
13. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced vascular endothelial growth factor expression in retina.
Lu M; Amano S; Miyamoto K; Garland R; Keough K; Qin W; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Gilbert RE; Kelly DJ; Cox AJ; Wilkinson-Berka JL; Rumble JR; Osicka T; Panagiotopoulos S; Lee V; Hendrich EC; Jerums G; Cooper ME
Diabetologia; 2000 Nov; 43(11):1360-7. PubMed ID: 11126403
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.
Gerhardinger C; Brown LF; Roy S; Mizutani M; Zucker CL; Lorenzi M
Am J Pathol; 1998 Jun; 152(6):1453-62. PubMed ID: 9626050
[TBL] [Abstract][Full Text] [Related]
19. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.
Chen YD; Xu X; Xia X; Wu H; Liu K; Zheng Z; Zhu D
Curr Eye Res; 2008 Nov; 33(11):977-83. PubMed ID: 19085380
[TBL] [Abstract][Full Text] [Related]
20. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
